Acklab Crema is used to treat herpes simplex virus infections of the lips (recurrent herpes labialis) in adults and adolescents (over 12 years of age).

Acklab Cream is administered according to the following doses:

• Adults and adolescents (age 'greater than 12 years): the medicine should be applied 5 times a day at intervals of about 4 hours, omitting the night application. The product should be applied to the lesions or areas where they are developing as early as possible after the onset of infection. It is particularly important to start treatment for recurrent episodes during the prodrome phase or at the first appearance of lesions. The treatment must continue for at least 5 days and up to a maximum of 10 if there is no healing. Patients should wash their hands before and after applying the cream and avoid unnecessarily rubbing the lesions or touching them with a towel in order to avoid worsening or transmission of the infection.
• Children younger than 12 years: the safety and efficacy of the product have not been studied in patients younger than 12 years.

 

The medicine should only be used for cold sores present on the lips. The product is not for ophthalmic use, nor is it advisable to apply it to the mucous membranes of the mouth or nose. The product should not be used in the treatment of genital herpes. Particular care should be taken to avoid accidental application into the eye. The use of the product especially if prolonged can give rise to sensitization phenomena, where this happens it is necessary to interrupt the treatment. No addiction or dependence phenomena have been reported to the drug.

 

It is recommended that people with particularly severe forms of recurrent cold sores consult their doctor. It is recommended that those suffering from cold sores avoid transmission of the virus particularly when active lesions are present. The safety and efficacy of the drug have not been studied in patients with impaired immune systems, therefore its use is not recommended in severely immunocompromised patients (AIDS patients or bone marrow transplant patients). Administration of aciclovir in oral formulations should be considered in these patients. It should also be recommended that such patients consult their physician regarding the treatment of any infections. Important information about some of the excipients: the methyl-para-hydroxybenzoate contained in the medicine can cause allergic reactions (even delayed).

• Pregnancy

A post-marketing registry of aciclovir use in pregnancy provided data on pregnancy outcomes in women exposed to the various aciclovir formulations. These observations did not show an increase in the number of birth defects among acyclovir exposed subjects compared to the general population and all birth defects found did not show any particularity or common characteristics, suggesting a single cause. The use of the drug should be considered only if the potential benefits outweigh the possibility of unknown risks.

• Feeding time

Limited data indicate that the drug is found in breast milk following systemic administration. However, the dose received by an infant following the use of the medicinal product in the mother should be insignificant.

Expiration and retention
Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored. After the first opening of the tube, the medicine must be used within 3 months; after this period, the residual medicinal product must be discarded. Store at a temperature not exceeding 25 ° C, do not refrigerate.

Warning: do not use the medicine after the expiry date indicated on the package.

 

Composition
Acklab Cream contains:
Active ingredient: Aciclovir 50 mg
Excipients: Tefose 1500, Glycerin, Stearic acid, Liquid paraffin, Methyl-para-hydroxybenzoate, Purified water.

 

Format
2g tube.